
Mike Fitzgibbons, CEO & Founder
ClaritasRx is an enterprise SaaS platform providing data management, data analytics, and patient engagement tools to biopharma companies focused on specialty therapeutics.

Their story
Specialty and orphan drug manufacturers face significant challenges in tracking, managing, and supporting patient access. Historically, manufacturers relied on fragmented consulting analyses, often receiving delayed, infrequent, and incomplete data that limited their ability to optimize patient outcomes and market performance.
Recognizing this gap, Mike Fitzgibbons founded ClaritasRx in 2012 after years at Genentech, developing a deep understanding of the industry’s data challenges. His team created Ascend, a data management and analytics platform that streamlines specialty drug fulfillment, providing manufacturers with a real-time, comprehensive view of drug performance and patient adherence.
ClaritasRx remains committed to using data-driven insights to help patients maximize the benefits of specialty therapies and ensure continued access to life-changing treatments.


.avif)


Our partnership
Our investment in ClaritasRx was the result of a multi-year research effort into how real-world data was being used in the complex specialty pharmacy market. We developed the relationship with the company and its Founder, Mike Fitzgibbons, over several years before having the opportunity to invest.
Since investing, we have been very active in recruiting senior leadership, strengthening and expanding the board of directors, and accelerating its investment in its commercialization and technology platforms to expand on its market leadership position.